HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
/in Breast Cancer, Dendritic Cells, International Publications /von 2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-402Virology- and immunology-based gene therapy for cancer
/in Dendritic Cells, International Publications /von 2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
/in Dendritic Cells, Hypernephroma, International Publications /von 2006-05-01 / Ai Zheng 2006 May;25(5):625-30Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
/in Dendritic Cells, International Publications, Prostate Cancer /von 2006-04-13 / Cancer Immunol. Immunother. 2006 Dec;55(12):1524-33Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2006-04-06 / Ann. Oncol. 2006 Jun;17(6):974-80Current state and perspectives of dendritic cell vaccination in cancer immunotherapy
/in Dendritic Cells, International Publications /von 2006-04-06 / Skin Pharmacol Physiol 2006;19(3):124-31Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
/in Dendritic Cells, Hyperthermia, International Publications /von 2006-03-03 / Biochem. Biophys. Res. Commun. 2006 Apr;343(1):269-78Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de